J.R. Caldera

791 total citations
17 papers, 219 citations indexed

About

J.R. Caldera is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, J.R. Caldera has authored 17 papers receiving a total of 219 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Infectious Diseases and 7 papers in Molecular Biology. Recurrent topics in J.R. Caldera's work include Antimicrobial Resistance in Staphylococcus (3 papers), Herpesvirus Infections and Treatments (3 papers) and Bacterial Identification and Susceptibility Testing (3 papers). J.R. Caldera is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (3 papers), Herpesvirus Infections and Treatments (3 papers) and Bacterial Identification and Susceptibility Testing (3 papers). J.R. Caldera collaborates with scholars based in United States, Spain and Taiwan. J.R. Caldera's co-authors include George Y. Liu, Chih‐Ming Tsai, Irshad A. Hajam, Robert H. Mills, Joshua Olson, Gregory D. Sepich‐Poore, Marvic Carrillo-Terrazas, George Sakoulas, Warren E. Rose and Shangxin Yang and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

J.R. Caldera

17 papers receiving 219 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.R. Caldera United States 7 102 91 56 43 22 17 219
Kathrin Stelzner Germany 5 128 1.3× 103 1.1× 51 0.9× 46 1.1× 75 3.4× 8 264
Marija Drikic Canada 10 169 1.7× 73 0.8× 56 1.0× 29 0.7× 14 0.6× 10 290
Melicent C. Peck United States 10 94 0.9× 106 1.2× 33 0.6× 69 1.6× 18 0.8× 15 433
Sophie Burbaud United Kingdom 5 117 1.1× 138 1.5× 40 0.7× 87 2.0× 16 0.7× 6 232
Andrea Hall United Kingdom 6 171 1.7× 217 2.4× 39 0.7× 59 1.4× 28 1.3× 8 298
Stéphane Schicklin France 8 77 0.8× 55 0.6× 51 0.9× 50 1.2× 10 0.5× 13 219
Nadine Nasreddine France 10 49 0.5× 142 1.6× 113 2.0× 38 0.9× 38 1.7× 11 330
Atsuko Hayashida United States 7 165 1.6× 106 1.2× 75 1.3× 31 0.7× 57 2.6× 11 358
Katja Schlatterer Germany 7 195 1.9× 107 1.2× 60 1.1× 39 0.9× 97 4.4× 7 333
Uday Tak United States 5 91 0.9× 115 1.3× 47 0.8× 101 2.3× 14 0.6× 7 253

Countries citing papers authored by J.R. Caldera

Since Specialization
Citations

This map shows the geographic impact of J.R. Caldera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.R. Caldera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.R. Caldera more than expected).

Fields of papers citing papers by J.R. Caldera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.R. Caldera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.R. Caldera. The network helps show where J.R. Caldera may publish in the future.

Co-authorship network of co-authors of J.R. Caldera

This figure shows the co-authorship network connecting the top 25 collaborators of J.R. Caldera. A scholar is included among the top collaborators of J.R. Caldera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.R. Caldera. J.R. Caldera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Caldera, J.R., et al.. (2025). Multi-Year Analysis of Respiratory Viral Dynamics Reveals Significance of Rhinovirus in Young Children with Severe Respiratory Illness. Infectious Disease Reports. 17(2). 29–29. 1 indexed citations
2.
Caldera, J.R., et al.. (2025). Development and validation of next-generation sequencing-based clinical test for triazole resistance prediction in Aspergillus fumigatus. Journal of Clinical Microbiology. 63(8). e0029125–e0029125. 1 indexed citations
3.
Tsai, Chih‐Ming, Irshad A. Hajam, J.R. Caldera, et al.. (2024). Pathobiont-driven antibody sialylation through IL-10 undermines vaccination. Journal of Clinical Investigation. 134(24). 6 indexed citations
4.
Tsai, Chih‐Ming, et al.. (2024). Pathobiont-induced suppressive immune imprints thwart T cell vaccine responses. Nature Communications. 15(1). 10335–10335. 4 indexed citations
5.
Caldera, J.R., Bennett Shaw, Daniel Z. Uslan, & Shangxin Yang. (2024). Cluster of extensively drug-resistant Shigella sonnei carrying blaCTX-M-15 in Los Angeles, California, 2023 to 2024. American Journal of Infection Control. 53(4). 524–526. 2 indexed citations
6.
Caldera, J.R., et al.. (2024). Performance Evaluation of a Commercial Automated Library Preparation System for Clinical Microbial Whole-Genome Sequencing Assays. Journal of Molecular Diagnostics. 26(8). 719–726. 2 indexed citations
7.
Caldera, J.R., Chih‐Ming Tsai, Irshad A. Hajam, et al.. (2024). The characteristics of pre-existing humoral imprint determine efficacy of S. aureus vaccines and support alternative vaccine approaches. Cell Reports Medicine. 5(1). 101360–101360. 12 indexed citations
8.
Caldera, J.R., et al.. (2023). FDA trial regulation of laboratory developed tests (LDTs): An academic medical center's experience with Mpox in-house testing. Journal of Clinical Virology. 169. 105611–105611. 3 indexed citations
9.
Hajam, Irshad A., Randall McNally, María Lázaro-Díez, et al.. (2023). Functional divergence of a bacterial enzyme promotes healthy or acneic skin. Nature Communications. 14(1). 8061–8061. 17 indexed citations
10.
Bredow, Benjamin von, et al.. (2023). Clinical next-generation sequencing assay combining full-length gene amplification and shotgun sequencing for the detection of CMV drug resistance mutations. Journal of Clinical Virology. 165. 105520–105520. 5 indexed citations
11.
Caldera, J.R., Shangxin Yang, & Daniel Z. Uslan. (2023). Extensively Drug-Resistant Shigella flexneri 2a, California, USA, 2022. Emerging infectious diseases. 29(7). 1473–1475. 4 indexed citations
12.
Caldera, J.R., et al.. (2023). Nosocomial infections by diverse carbapenemase-producing Aeromonas hydrophila associated with combination of plumbing issues and heat waves. American Journal of Infection Control. 52(3). 337–343. 8 indexed citations
13.
Tsai, Chih‐Ming, J.R. Caldera, Irshad A. Hajam, et al.. (2022). Non-protective immune imprint underlies failure of Staphylococcus aureus IsdB vaccine. Cell Host & Microbe. 30(8). 1163–1172.e6. 52 indexed citations
14.
Tsai, Chih‐Ming, Irshad A. Hajam, J.R. Caldera, & George Y. Liu. (2022). Integrating complex host-pathogen immune environments into S. aureus vaccine studies. Cell chemical biology. 29(5). 730–740. 10 indexed citations
15.
Prabaker, Kavitha, Annabelle de St. Maurice, Daniel Z. Uslan, et al.. (2022). Case Report: Symptomatic Herpes Simplex Virus Type 2 and Monkeypox Coinfection in an Adult Male. American Journal of Tropical Medicine and Hygiene. 107(6). 1258–1260. 5 indexed citations
16.
Caldera, J.R., Christopher Nguyen, Purnima Sharma, et al.. (2020). Harnessing antifungal immunity in pursuit of a Staphylococcus aureus vaccine strategy. PLoS Pathogens. 16(8). e1008733–e1008733. 16 indexed citations
17.
Wozniak, Jacob M., Robert H. Mills, Joshua Olson, et al.. (2020). Mortality Risk Profiling of Staphylococcus aureus Bacteremia by Multi-omic Serum Analysis Reveals Early Predictive and Pathogenic Signatures. Cell. 182(5). 1311–1327.e14. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathrin Stelzner Breakdown of academic impact, for papers by Marija Drikic Breakdown of academic impact, for papers by Melicent C. Peck Breakdown of academic impact, for papers by Sophie Burbaud Breakdown of academic impact, for papers by Andrea Hall Breakdown of academic impact, for papers by Stéphane Schicklin Breakdown of academic impact, for papers by Nadine Nasreddine Breakdown of academic impact, for papers by Atsuko Hayashida Breakdown of academic impact, for papers by Katja Schlatterer Breakdown of academic impact, for papers by Uday Tak
Rankless by CCL
2026